Percutaneous pulmonary endoarterial biopsy in an experimental model of pulmonary hypertension

Chest

Volumn 114, Issue 1, 1998, Pages 241-250

  Rothman, Abraham ^a,e   Mann, David M ^d   Behling, Cynthia A ^c   Konopka, Ron G ^b   Chiles, Peter G ^b   Pedersen, Craig A ^b   Moser, Kenneth M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Vascular BioSciences Co   (United States)

^e UCSD MEDICAL CENTER   (United States)

Author keywords

Endoarterial biopsy catheter; Pulmonary artery; Pulmonary hypertension

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; ENDOVASCULAR SURGERY; HISTOPATHOLOGY; LUNG ANGIOGRAPHY; LUNG BIOPSY; LUNG VASCULAR RESISTANCE; NONHUMAN; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TISSUE SECTION; VASCULAR ENDOTHELIUM;

EID: 0031845207     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1.241     Document Type: Article

References (27)

1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336:111-17
2. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115:343-49
3. Glanville AR, Burke CM, Theodore J, et al. Primary pulmonary hypertension: length of survival in patients referred for heart-lung transplantation. Chest 1987; 91:675-81
4. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216-23
5. Rich S, Chomka E, Hasara L, et al. The prevalence of pulmonary hypertension in the United States: adult population estimates obtained from measurements of chest roentgenograms from the NHANES II survey. Chest 1989; 96: 236-41
6. Rich S, Brundage BH. Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. J Am Coll Cardiol 1989; 14:545-50
7. Perkin RM, Anas NG. Pulmonary hypertension in pediatric patients. J Pediatr 1984; 105:511-22
8. Sandoval J, Bauerle O, Gomez A, et al. Primary pulmonary hypertension in children: clinical characterization and survival. J Am Coll Cardiol 1995; 25:466-74
9. Rothman A, Mann DM, House MT, et al. Transvenous procurement of pulmonary artery smooth muscle and endothelial cells using a novel endoarterial biopsy catheter in a canine model. J Am Coll Cardiol 1996; 27:218-24
10. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18: 533-47
11. Rabinovitch M. Pathophysiology of pulmonary hypertension. In: Emmanouilides GC, Riemenschneider TA, Allen HD, et al, eds. Heart disease in infants, children and adolescents. 5th ed. Baltimore: Williams & Wilkins, 1995; 1659-95
12. Hoffman JIE, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 1981; 64:873-77
13. Newfeld EA, Paul MH, Muster AJ, et al. Pulmonary vascular disease in complete transposition of the great arteries: a study of 200 patients. Am J Cardiol 1974; 34:75-82
14. Haworth SG. Pulmonary vascular disease in secundum atrial septal defect in childhood. Am J Cardiol 1983; 51:265-72
15. Smith P, Heath D, Yacoub M, et al. The ultrastructure of plexogenic pulmonary arteriopathy. J Pathol 1990; 160:111-21
16. Lakier JB, Stanger P, Heymann MA, et al. Early onset of pulmonary vascular obstruction in patients with aortopulmonary transposition and intact ventricular septum. Circulation 1975; 51:875-80
17. Gomez-Sanchez MA, Saenz De La Calzada C, et al. Clinical and pathologic manifestations of pulmonary vascular disease in the toxic oil syndrome. J Am Coll Cardiol 1991; 18:1539-45
18. Anderson EG, Simon G, Reid L. Primary and thromboembolic pulmonary hypertension: a quantitative pathological study. J Pathol 1973; 110:273-93
19. Pietra GG, Edwards WD, Kay JM, et al. Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 1989; 80:1198-1206
20. Palevsky HI, Schloo BL, Pietra GG, et al. Primary pulmonary hypertension: vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation 1989; 80:1207-21
21. Thilenius OG, Nadas AS, Jockin H. Primary pulmonary vascular obstruction in children. Pediatrics 1965; 36:75-87
22. Rabinovitch M, Haworth SG, Castaneda AR, et al. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978; 58:1107-21
23. Loscalzo J. Endothelial dysfunction in pulmonary hypertension. N Engl J Med 1992; 327:117-19
24. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333:214-21
25. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327:70-75
26. 2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Circulation 1993; 88(Part 1): 2117-22
27. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328:1732-39